Skip to main content
. Author manuscript; available in PMC: 2020 Oct 13.
Published in final edited form as: Leukemia. 2018 Jan 30;32(10):2203–2210. doi: 10.1038/s41375-018-0027-y

Figure 2.

Figure 2.

Hazard ratio of second non-melanoma skin cancer for patients with myeloproliferative neoplasms (MPN) compared to matched population controls, in relation to time from MPN diagnosis